AIDS (London, England) · 2026
Heterogeneity of baseline immune activation and SARS-CoV-2 vaccine responses in people with HIV: a multicenter prospective study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
El Moussaoui Majdouline, Ladang Aurélie, Maes Nathalie, Cavalier Etienne, Genderini Francesco, Dahma Hafid, Martin Charlotte, Dauby Nicolas, Darcis Gilles
Аннотация
OBJECTIVE: The aim of this study was to determine whether baseline immune activation and inflammation contribute to heterogeneity in SARS-CoV-2 vaccine-induced immunity in antiretroviral therapy (ART)-treated people with HIV (PWH) compared to controls.
METHODS: In this multicenter prospective study, 159 ART-treated PWH from two cohorts and 56 HIV-negative controls were enrolled. The two PWH cohorts differed in immunovirological control: one showed sustained viral suppression and CD4 + T-cell recovery, the other persistent CD4 + T-cell lymphopenia despite ART, sometimes with residual viremia. Baseline plasma levels of 20 cytokines, chemokines and soluble endothelial markers, were measured before SARS-CoV-2 mRNA vaccination. Post-vaccination anti-spike IgG, neutralizing antibodies, and IFN-γ-producing T cells were quantified and correlated with baseline immune mediators.
RESULTS: PWH had higher baseline levels of innate immune activation and endothelial inflammation markers than controls, particularly among immunological nonresponders. Principal component analysis identified two inflammatory profile groups among PWH: one characterized by Th1/Th17-oriented cytokine profile, and the other with dominant monocyte activation and endothelial markers. Higher baseline inflammation in PWH was associated with reduced humoral vaccine responses and elevated ICAM-1 levels with decreased IFN-γ T-cell responses, irrespective of prior SARS-CoV-2 infection. In contrast, among HIV-negative participants with prior SARS-CoV-2 exposure, higher sCD14, IL-12p70, MCP-1, and E-selectin levels correlated with stronger humoral responses, whereas ICAM-1 was associated with increased IFN-γ T-cell responses.
CONCLUSION: Baseline inflammatory and endothelial profiles may constitute additional determinants of SARS-CoV-2 vaccine-induced immune responses in PWH. The opposite associations observed in controls highlight the context-dependent immunological effects of these pathways across chronic immune dysfunction and immunocompetent states.
METHODS: In this multicenter prospective study, 159 ART-treated PWH from two cohorts and 56 HIV-negative controls were enrolled. The two PWH cohorts differed in immunovirological control: one showed sustained viral suppression and CD4 + T-cell recovery, the other persistent CD4 + T-cell lymphopenia despite ART, sometimes with residual viremia. Baseline plasma levels of 20 cytokines, chemokines and soluble endothelial markers, were measured before SARS-CoV-2 mRNA vaccination. Post-vaccination anti-spike IgG, neutralizing antibodies, and IFN-γ-producing T cells were quantified and correlated with baseline immune mediators.
RESULTS: PWH had higher baseline levels of innate immune activation and endothelial inflammation markers than controls, particularly among immunological nonresponders. Principal component analysis identified two inflammatory profile groups among PWH: one characterized by Th1/Th17-oriented cytokine profile, and the other with dominant monocyte activation and endothelial markers. Higher baseline inflammation in PWH was associated with reduced humoral vaccine responses and elevated ICAM-1 levels with decreased IFN-γ T-cell responses, irrespective of prior SARS-CoV-2 infection. In contrast, among HIV-negative participants with prior SARS-CoV-2 exposure, higher sCD14, IL-12p70, MCP-1, and E-selectin levels correlated with stronger humoral responses, whereas ICAM-1 was associated with increased IFN-γ T-cell responses.
CONCLUSION: Baseline inflammatory and endothelial profiles may constitute additional determinants of SARS-CoV-2 vaccine-induced immune responses in PWH. The opposite associations observed in controls highlight the context-dependent immunological effects of these pathways across chronic immune dysfunction and immunocompetent states.